CHERYL CAMPBELL: Open Payments
NPI 1700960952 · VICTORIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 10 payments from 8 companies in 2025. Trend: 2023 $344 · 2024 $133 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 2 | $166 |
| Gilead Sciences, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $119 |
| Corcept Therapeutics | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 1 | $44 |
| Organogenesis Inc. | 2 | $41 |
| Integra LifeSciences Corporation | 1 | $17 |
| Medline Industries LP | 1 | $14 |
Products named: Kerecis SurgiClose, Livdelzi, DALVANCE, Korlym, AIRSUPRA, APLIGRAF, NUSHIELD, TCC-EZ.
Industry payments across TX — which companies pay providers there.
